GNFTF Message Board Post 9866536 | Genfit Ord
home / stock / gnftf / gnftf message board
grace3St
(investorshub)
Posted on: Jun/23/2017 15:23:36
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132439141
Genfit claims advance in non-invasive NASH diagnostic: #msg-132439027.
News, Short Squeeze, Breakout and More Instantly...
-
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the inclusi...
-
Ipsen’s Iqirvo ® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC) First-ever drug developed in-house by GENFIT to achieve U.S. FDA’s approval GENFIT is eligible to ...
-
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed its presence ...